Medication Abortion

Doctor-messengers are valuable communicators about abortion, impact of the shot on medication abortion efficacy, common misconceptions about IUDs, and precoital EC.

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

Patient characteristics of IUD placement under sedation, two studies on EC efficacy, substance use and anxiety among patients seeking an abortion, and genital herpes prevalence.

A patient-centered decision aid for tubal sterilization counseling, IUD self-removal experiences, and counseling about pain and medication abortion.

Answers for health care providers about birth control options after abortion

Young people’s concerns about birth control and fertility, expanding EPT and PrEP in the ED, spike in EC demand around the New Year, and abortion decision making.

Highlighting one notable research article from each Research Roundup in 2023.

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.